|
|
|
|
|
|
|
Innoviva Inc. (INVA)
|
|
15.51 -0.23 (-1.46%)
|
10-23 15:14
|
|
Open:
|
15.56
|
Pre. Close:
|
15.74
|
|
High:
|
15.75
|
Low:
|
15.36
|
|
Volume:
|
690,026
|
Market Cap:
|
1574M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
15.829 - 15.89
|
15.89 - 15.951
|
|
Low:
|
15.477 - 15.552
|
15.552 - 15.626
|
|
Close:
|
15.621 - 15.734
|
15.734 - 15.847
|
|
|
|
Technical analysis (as of: 2018-10-23 2:53:11 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 18.65 One year: 21.79
|
|
Support:
|
Support1: 15.04 Support2: 14.46
|
|
Resistance:
|
Resistance1:
15.97 Resistance2: 18.65
|
|
Pivot:
|
15.31
|
|
Moving Averages:
|
MA(5): 15.54  MA(20): 15.33
MA(100): 14.55 MA(250): 14.63
|
|
MACD:
|
MACD(12,26):
0.16 Signal(12,26,9): 0.15
|
|
%K %D:
|
%K(14,3): 77.48 %D(3): 74.17
|
|
RSI:
|
RSI(14): 56.04
|
|
52-Week:
|
High: 17.99
Low: 11.47 Change(%): 31.9
|
|
Average Vol(K):
|
3-Month: 72060
10-Days 79689
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.INVA has closed below upper band by 38.3%. Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-09-21T08:32:30-04:00
European advisory group backs expanded use for Glaxo's Trelegy Ellipta
2018-09-21T07:30:00-04:00
Trelegy Ellipta Receives Positive CHMP Opinion Supporting Expanded COPD Indication in Europe
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
